REGEN BIOPHARMA, INC. Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest
REGEN BIOPHARMA, INC. (RGBP) reported Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest · last filed 2021-08-05
- REGEN BIOPHARMA, INC. net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2020-03-31 was $0.00.
- REGEN BIOPHARMA, INC. net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2019-03-31 was -$2.50K.
| Period end | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 6 month |
|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 |
| 2019-03-31 | -$2.50K 10-Q · filed 2021-08-05 | -$2.50K 10-Q · filed 2021-08-05 |